Atlas Trials

Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD)

Clinical trial NCT02397889 · COMPLETED

Trial details

NCT number
NCT02397889
Sponsor
Icahn School of Medicine at Mount Sinai
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Posttraumatic Stress Disorder (PTSD)
Start date
2015-05-18
Primary completion
2020-01-27
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.